Modification of the actin interface of skeletal myosin subfragment-1 by treatment with dibromobimane. 1986

D Mornet, and K Ue, and P Chaussepied, and M F Morales

Recently, by treating the head portion of skeletal myosin subfragment-1 (S1) with the bifunctional agent dibromobimane, we introduced an intramolecular covalent cross-link which resulted in the stabilisation of an internal loop in the heavy chain structure of the head [Mornet et al. (1984) Proc. Natl Acad. Sci. USA 82, 1658-1662]. In order to define the functional properties of this new S1 conformational state, we have first determined the experimental conditions for the optimum modification of S1 by dibromobimane. We finally settled on a 60% yield of cross-linked S1. Because the modification occurs between the 50-kDa and the 20-kDa tryptic heavy chain fragments which have been postulated to be involved in the interaction of native S1 with actin, we have investigated the association of dibromobimane-treated S1 with actin, using chemical cross-linking of their rigor complex with 1-ethyl-3-[3-(dimethylamino)propyl] carbodiimide. The cross-linked species obtained were analyzed by polyacrylamide gel electrophoresis and compared with those known for unmodified S1. The carbodiimide-catalyzed linkage between actin and dibromobimane-modified S1 led to a singlet protein band migrating with an apparent molecular mass of 155 kDa, in contrast to the usual doublet bands of 175 kDa and 185 kDa produced with native S1. This result suggests that a change has occurred at the actin interface on the dibromobimane-treated S1 heavy chain. The covalent complex generated by carbodiimide cross-linking between actin and dibromobimane-modified S1 (27-kDa + 50-kDa + 20-kDa fragments) was submitted to chemical hydrolysis with hydroxylamine. The nature of the products identified is consistent with the conclusion that the internal freezing of the heavy chain structure by dibromobimane induces the loss of the ability to cross-linkage of the actin site on the 20-kDa domain but does not affect the conformation of the second site on the 50-kDa segment, which becomes the unique actin region cross-linkable by actin.

UI MeSH Term Description Entries
D009218 Myosins A diverse superfamily of proteins that function as translocating proteins. They share the common characteristics of being able to bind ACTINS and hydrolyze MgATP. Myosins generally consist of heavy chains which are involved in locomotion, and light chains which are involved in regulation. Within the structure of myosin heavy chain are three domains: the head, the neck and the tail. The head region of the heavy chain contains the actin binding domain and MgATPase domain which provides energy for locomotion. The neck region is involved in binding the light-chains. The tail region provides the anchoring point that maintains the position of the heavy chain. The superfamily of myosins is organized into structural classes based upon the type and arrangement of the subunits they contain. Myosin ATPase,ATPase, Actin-Activated,ATPase, Actomyosin,ATPase, Myosin,Actin-Activated ATPase,Actomyosin ATPase,Actomyosin Adenosinetriphosphatase,Adenosine Triphosphatase, Myosin,Adenosinetriphosphatase, Actomyosin,Adenosinetriphosphatase, Myosin,Myosin,Myosin Adenosinetriphosphatase,ATPase, Actin Activated,Actin Activated ATPase,Myosin Adenosine Triphosphatase
D010446 Peptide Fragments Partial proteins formed by partial hydrolysis of complete proteins or generated through PROTEIN ENGINEERING techniques. Peptide Fragment,Fragment, Peptide,Fragments, Peptide
D001952 Bridged-Ring Compounds Cyclic hydrocarbons that contain multiple rings which share one or more bridgehead connections. Bridged Compounds,Bridged Ring Compounds
D003432 Cross-Linking Reagents Reagents with two reactive groups, usually at opposite ends of the molecule, that are capable of reacting with and thereby forming bridges between side chains of amino acids in proteins; the locations of naturally reactive areas within proteins can thereby be identified; may also be used for other macromolecules, like glycoproteins, nucleic acids, or other. Bifunctional Reagent,Bifunctional Reagents,Cross Linking Reagent,Crosslinking Reagent,Cross Linking Reagents,Crosslinking Reagents,Linking Reagent, Cross,Linking Reagents, Cross,Reagent, Bifunctional,Reagent, Cross Linking,Reagent, Crosslinking,Reagents, Bifunctional,Reagents, Cross Linking,Reagents, Cross-Linking,Reagents, Crosslinking
D005022 Ethyldimethylaminopropyl Carbodiimide Carbodiimide cross-linking reagent. 1-Ethyl-3-(3-Dimethylaminopropyl)Carbodiimide,3-(3-Dimethylaminopropyl)-1-Ethylcarbodiimide,EDAP-Carbodiimide,Carbodiimide, Ethyldimethylaminopropyl,EDAP Carbodiimide
D006898 Hydroxylamines Organic compounds that contain the (-NH2OH) radical.
D000199 Actins Filamentous proteins that are the main constituent of the thin filaments of muscle fibers. The filaments (known also as filamentous or F-actin) can be dissociated into their globular subunits; each subunit is composed of a single polypeptide 375 amino acids long. This is known as globular or G-actin. In conjunction with MYOSINS, actin is responsible for the contraction and relaxation of muscle. F-Actin,G-Actin,Actin,Isoactin,N-Actin,alpha-Actin,alpha-Isoactin,beta-Actin,gamma-Actin,F Actin,G Actin,N Actin,alpha Actin,alpha Isoactin,beta Actin,gamma Actin
D001643 Bridged Bicyclo Compounds Saturated alicyclic hydrocarbon molecules consisting of two rings that have two non-adjacent atoms in common. Bicyclo Compounds,Bicyclo Compounds, Bridged
D015879 Myosin Subfragments Parts of the myosin molecule resulting from cleavage by proteolytic enzymes (PAPAIN; TRYPSIN; or CHYMOTRYPSIN) at well-localized regions. Study of these isolated fragments helps to delineate the functional roles of different parts of myosin. Two of the most common subfragments are myosin S-1 and myosin S-2. S-1 contains the heads of the heavy chains plus the light chains and S-2 contains part of the double-stranded, alpha-helical, heavy chain tail (myosin rod). Actomyosin Subfragments,Meromyosin Subfragments,Myosin Rod,Myosin S-1,Myosin S-2,ATPase, Actin-S1,Actin S1 ATPase,Actoheavy Meromyosin,Actomyosin Subfragment 1 ATPase,H-Meromyosin,Heavy Meromyosin,Heavy Meromyosin Subfragment-1,Heavy Meromyosin Subfragment-2,Light Meromyosin,Myosin Subfragment-1,Myosin Subfragment-2,ATPase, Actin S1,Actin-S1 ATPase,H Meromyosin,Heavy Meromyosin Subfragment 1,Heavy Meromyosin Subfragment 2,Meromyosin Subfragment-1, Heavy,Meromyosin Subfragment-2, Heavy,Meromyosin, Actoheavy,Meromyosin, Heavy,Meromyosin, Light,Myosin S 1,Myosin S 2,Myosin Subfragment 1,Myosin Subfragment 2,Subfragment-1, Heavy Meromyosin,Subfragment-1, Myosin,Subfragment-2, Heavy Meromyosin,Subfragment-2, Myosin,Subfragments, Actomyosin,Subfragments, Meromyosin,Subfragments, Myosin

Related Publications

D Mornet, and K Ue, and P Chaussepied, and M F Morales
February 1985, The Journal of biological chemistry,
D Mornet, and K Ue, and P Chaussepied, and M F Morales
May 1994, The Biochemical journal,
D Mornet, and K Ue, and P Chaussepied, and M F Morales
September 1990, Biochemistry,
D Mornet, and K Ue, and P Chaussepied, and M F Morales
February 1988, The Journal of biological chemistry,
D Mornet, and K Ue, and P Chaussepied, and M F Morales
April 1987, The Journal of biological chemistry,
D Mornet, and K Ue, and P Chaussepied, and M F Morales
October 1988, The Journal of biological chemistry,
D Mornet, and K Ue, and P Chaussepied, and M F Morales
September 1968, Biochemistry,
D Mornet, and K Ue, and P Chaussepied, and M F Morales
July 1996, Journal of biochemistry,
D Mornet, and K Ue, and P Chaussepied, and M F Morales
May 1991, Biochemistry,
Copied contents to your clipboard!